MedTrace Logo

Effect of Korean Red Ginseng on Central Blood Pressure in Patient With Essential Hypertension

NCT02211352 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2014-08-07

No results posted yet for this study

Summary

The purpose of this study is to determine Korean red ginseng (KRG)treatment could decrease central blood pressure in subjects with hypertension.

Conditions

Interventions

DRUG

Korean Red Ginseng Capsules

Korean Red Ginseng Capsules 2mg,daily, 8 week and than crossover to placebo capsules(2g), daily 8week

DRUG

Placebo

Korean Red Ginseng Capsules 2mg,daily, 8 week and than crossover to placebo capsules(2g), daily 8week

Sponsors & Collaborators

  • The Korean Society of Ginseng

    collaborator OTHER

  • Daegu Catholic University Medical Center

    lead OTHER

Principal Investigators

  • Jin Bae Lee, MD, PhD · Daegu Catholic University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-12-31
Completion
2014-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02211352 on ClinicalTrials.gov